JP2018077253A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018077253A5 JP2018077253A5 JP2018004851A JP2018004851A JP2018077253A5 JP 2018077253 A5 JP2018077253 A5 JP 2018077253A5 JP 2018004851 A JP2018004851 A JP 2018004851A JP 2018004851 A JP2018004851 A JP 2018004851A JP 2018077253 A5 JP2018077253 A5 JP 2018077253A5
- Authority
- JP
- Japan
- Prior art keywords
- mass spectrometry
- liquid chromatography
- amount
- ionization
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461992214P | 2014-05-12 | 2014-05-12 | |
| US61/992,214 | 2014-05-12 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016567654A Division JP6279104B2 (ja) | 2014-05-12 | 2015-05-12 | 質量分析によるタモキシフェンおよびその代謝産物の定量化 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021000689A Division JP2021073450A (ja) | 2014-05-12 | 2021-01-06 | 質量分析によるタモキシフェンおよびその代謝産物の定量化 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018077253A JP2018077253A (ja) | 2018-05-17 |
| JP2018077253A5 true JP2018077253A5 (enExample) | 2018-06-28 |
| JP6821610B2 JP6821610B2 (ja) | 2021-01-27 |
Family
ID=54367635
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016567654A Active JP6279104B2 (ja) | 2014-05-12 | 2015-05-12 | 質量分析によるタモキシフェンおよびその代謝産物の定量化 |
| JP2018004851A Active JP6821610B2 (ja) | 2014-05-12 | 2018-01-16 | 質量分析によるタモキシフェンおよびその代謝産物の定量化 |
| JP2021000689A Pending JP2021073450A (ja) | 2014-05-12 | 2021-01-06 | 質量分析によるタモキシフェンおよびその代謝産物の定量化 |
| JP2023080724A Pending JP2023109874A (ja) | 2014-05-12 | 2023-05-16 | 質量分析によるタモキシフェンおよびその代謝産物の定量化 |
| JP2025018885A Pending JP2025081382A (ja) | 2014-05-12 | 2025-02-07 | 質量分析によるタモキシフェンおよびその代謝産物の定量化 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016567654A Active JP6279104B2 (ja) | 2014-05-12 | 2015-05-12 | 質量分析によるタモキシフェンおよびその代謝産物の定量化 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021000689A Pending JP2021073450A (ja) | 2014-05-12 | 2021-01-06 | 質量分析によるタモキシフェンおよびその代謝産物の定量化 |
| JP2023080724A Pending JP2023109874A (ja) | 2014-05-12 | 2023-05-16 | 質量分析によるタモキシフェンおよびその代謝産物の定量化 |
| JP2025018885A Pending JP2025081382A (ja) | 2014-05-12 | 2025-02-07 | 質量分析によるタモキシフェンおよびその代謝産物の定量化 |
Country Status (9)
| Country | Link |
|---|---|
| US (7) | US9459267B2 (enExample) |
| EP (2) | EP3143392B1 (enExample) |
| JP (5) | JP6279104B2 (enExample) |
| CN (2) | CN106537139B (enExample) |
| AU (5) | AU2015259294A1 (enExample) |
| BR (1) | BR112016026459B1 (enExample) |
| CA (1) | CA2948823C (enExample) |
| SA (1) | SA516380291B1 (enExample) |
| WO (1) | WO2015175561A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8153962B2 (en) * | 2008-12-24 | 2012-04-10 | Quest Diagnostics Investments Incorporated | Mass spectrometry assay for congenital adrenal hyperplasia |
| EP3143392B1 (en) | 2014-05-12 | 2023-02-22 | Quest Diagnostics Investments Incorporated | Quantitation of tamoxifen metabolites by mass spectrometry |
| CN105159539B (zh) * | 2015-09-10 | 2018-06-01 | 京东方科技集团股份有限公司 | 可穿戴设备的触控响应方法、装置及可穿戴设备 |
| CN114585915B (zh) | 2019-10-10 | 2024-02-23 | 瑞泽恩制药公司 | 用于分析两性电解质批次变化的液相色谱法-质谱法(lc-ms)方法 |
| KR20220136376A (ko) | 2020-01-31 | 2022-10-07 | 리제너론 파마슈티칼스 인코포레이티드 | 올리고뉴클레오티드의 특성을 분석하기 위한 액체 크로마토그래피 및 질량 분광분석의 용도 |
| US12105102B2 (en) | 2022-03-30 | 2024-10-01 | University Of Utah Research Foundation | Methods for quantifying insulin-like growth factor-1 and insulin-like growth factor-2 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5119827A (en) * | 1990-09-05 | 1992-06-09 | Board Of Regents, The University Of Texas System | Mechanisms of antiestrogen resistance in breast cancer |
| US5605798A (en) | 1993-01-07 | 1997-02-25 | Sequenom, Inc. | DNA diagnostic based on mass spectrometry |
| WO1994028418A1 (en) | 1993-05-28 | 1994-12-08 | Baylor College Of Medicine | Method and apparatus for desorption and ionization of analytes |
| IES950928A2 (en) * | 1995-12-08 | 1996-02-21 | Bunskellig Limited | "A process for analysing a fluid" |
| GB9717926D0 (en) | 1997-08-22 | 1997-10-29 | Micromass Ltd | Methods and apparatus for tandem mass spectrometry |
| AU2463299A (en) | 1998-01-23 | 1999-08-09 | Analytica Of Branford, Inc. | Mass spectrometry from surfaces |
| CN1871517A (zh) * | 2002-02-19 | 2006-11-29 | 免疫公司 | 快速有效分离循环癌细胞的方法和试剂 |
| EP1952809B1 (en) * | 2002-12-18 | 2017-08-02 | Besins Healthcare Luxembourg SARL | Formulations for the reduction of breast density with 4-Hydroxy Tamoxifen |
| ES2483896T3 (es) * | 2003-04-01 | 2014-08-08 | Besins Healthcare Luxembourg Sarl | Prevención y tratamiento de cáncer de seno con 4-hidroxi tamoxifen |
| DE602004027839D1 (de) * | 2003-12-26 | 2010-08-05 | Takeda Pharmaceutical | Verfahren zur vorhersage von anomalien des lipidmetabolismus |
| MY145634A (en) * | 2003-12-29 | 2012-03-15 | Bristol Myers Squibb Co | Pyrrolotriazine compounds as kinase inhibitors |
| US20060105045A1 (en) * | 2004-11-08 | 2006-05-18 | Buchanan Charles M | Cyclodextrin solubilizers for liquid and semi-solid formulations |
| US20090291134A1 (en) * | 2006-11-21 | 2009-11-26 | Jina Pharmaceuticals, Inc. | Endoxifen methods and compositions in the treatment of psychiatric and neurodegenerative diseases |
| US8017403B2 (en) * | 2007-06-14 | 2011-09-13 | Quest Diagnostics Investments Incorporated | Mass spectrometry method for measuring vitamin B6 in body fluid |
| US20090134325A1 (en) * | 2007-11-27 | 2009-05-28 | Goldman Mildred M | Methods for detecting estradiol by mass spectrometry |
| US8916385B2 (en) * | 2007-12-13 | 2014-12-23 | Quest Diagnostics Investments, Inc. | Methods for detecting estrone by mass spectrometry |
| US7834313B2 (en) | 2008-08-08 | 2010-11-16 | Quest Diagnostics Investments Incorporated | Mass spectrometry assay for plasma-renin |
| CA2751888C (en) * | 2009-02-11 | 2022-06-14 | Caris Mpi, Inc. | Molecular profiling of tumors |
| CA2776383C (en) * | 2009-10-06 | 2019-04-30 | Wisconsin Alumni Research Foundation | Metabolic biomarkers of drug-induced cardiotoxicity |
| WO2012119010A2 (en) * | 2011-03-01 | 2012-09-07 | Indiana University Research And Technology Corporation | Materials for inhibiting aromatase and method of using the same to diagnose, treat and monitor breast cancer |
| WO2012167126A1 (en) * | 2011-06-03 | 2012-12-06 | Purdue Research Foundation | Ion generation using modified wetted porous materials |
| EP2822955B1 (en) * | 2012-03-05 | 2017-07-26 | Xavier University | Boron-based 4-hydroxytamoxifen and endoxifen prodrugs as treatment for breast cancer |
| EP2876434A4 (en) * | 2012-07-17 | 2016-05-04 | Snu R&Db Foundation | METHOD FOR IMPROVING THE REPRODUCIBILITY OF A MASS SPECTRUM AND QUANTITATIVE ANALYSIS METHOD THEREWITH |
| CN103494787B (zh) * | 2013-07-22 | 2014-10-29 | 南通广泰生化制品有限公司 | 枸橼酸他莫昔芬滴丸 |
| EP3143392B1 (en) * | 2014-05-12 | 2023-02-22 | Quest Diagnostics Investments Incorporated | Quantitation of tamoxifen metabolites by mass spectrometry |
-
2015
- 2015-05-12 EP EP15793289.8A patent/EP3143392B1/en active Active
- 2015-05-12 BR BR112016026459-2A patent/BR112016026459B1/pt active IP Right Grant
- 2015-05-12 AU AU2015259294A patent/AU2015259294A1/en not_active Abandoned
- 2015-05-12 CA CA2948823A patent/CA2948823C/en active Active
- 2015-05-12 JP JP2016567654A patent/JP6279104B2/ja active Active
- 2015-05-12 CN CN201580037630.9A patent/CN106537139B/zh active Active
- 2015-05-12 WO PCT/US2015/030419 patent/WO2015175561A1/en not_active Ceased
- 2015-05-12 US US14/710,311 patent/US9459267B2/en active Active
- 2015-05-12 EP EP23157017.7A patent/EP4220178A3/en active Pending
- 2015-05-12 CN CN201910220665.6A patent/CN110044998B/zh active Active
-
2016
- 2016-10-03 US US15/284,248 patent/US9835606B2/en active Active
- 2016-11-13 SA SA516380291A patent/SA516380291B1/ar unknown
-
2017
- 2017-12-04 US US15/830,812 patent/US10830746B2/en active Active
-
2018
- 2018-01-16 JP JP2018004851A patent/JP6821610B2/ja active Active
- 2018-12-07 AU AU2018275011A patent/AU2018275011A1/en not_active Abandoned
-
2020
- 2020-09-23 AU AU2020239700A patent/AU2020239700B2/en active Active
- 2020-11-09 US US17/093,472 patent/US11428682B2/en active Active
-
2021
- 2021-01-06 JP JP2021000689A patent/JP2021073450A/ja active Pending
-
2022
- 2022-04-20 AU AU2022202628A patent/AU2022202628B2/en active Active
- 2022-08-23 US US17/893,950 patent/US11835505B2/en active Active
-
2023
- 2023-05-16 JP JP2023080724A patent/JP2023109874A/ja active Pending
- 2023-07-07 AU AU2023204389A patent/AU2023204389B2/en active Active
- 2023-10-25 US US18/494,030 patent/US12270803B2/en active Active
-
2025
- 2025-02-07 JP JP2025018885A patent/JP2025081382A/ja active Pending
- 2025-03-07 US US19/074,121 patent/US20260118337A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Berg et al. | 13C labelled internal standards—A solution to minimize ion suppression effects in liquid chromatography–tandem mass spectrometry analyses of drugs in biological samples? | |
| Gould et al. | Breath analysis for detection of viral infection, the current position of the field | |
| JP2017516104A5 (enExample) | ||
| Helm et al. | Ion mobility tandem mass spectrometry enhances performance of bottom-up proteomics | |
| JP2011504596A5 (enExample) | ||
| JP2011505013A5 (enExample) | ||
| JP2011530701A5 (enExample) | ||
| JP2013513802A5 (enExample) | ||
| Fukuyama et al. | Alkylated dihydroxybenzoic acid as a MALDI matrix additive for hydrophobic peptide analysis | |
| EP3570315A3 (en) | Rapid evaporative ionisation mass spectrometry ("reims") and desorption electrospray ionisation mass spectrometry ("desi-ms") analysis of biopsy samples | |
| WO2006130474A3 (en) | Multi-beam ion mobility time-of-flight mass spectrometer with bipolar ion extraction and zwitterion detection | |
| WO2009140849A1 (zh) | 双面离子源 | |
| Chingin et al. | Rapid recognition of bacteremia in humans using atmospheric pressure chemical ionization mass spectrometry of volatiles emitted by blood cultures | |
| Wong et al. | Advances in rapid detection of SARS-CoV-2 by mass spectrometry | |
| JP2020507883A5 (enExample) | ||
| SA516380291B1 (ar) | الحساب الكمي لتاموكسيفين ونواتج أيضه بواسطة القياس الطيفي الكتلي | |
| Liu et al. | Matrix effects in the liquid chromatography-tandem mass spectrometry method of analysis | |
| RU2018104707A (ru) | ИСПОЛЬЗОВАНИЕ МОЛЕКУЛЯРНЫХ МАРКЕРОВ IL-3, IL-33 и IL12ρ40 ДЛЯ ХАРАКТЕРИСТИКИ СТЕПЕНИ ТЯЖЕСТИ РЕСПИРАТОРНЫХ ИНФЕКЦИЙ, ВЫЗВАННЫХ РЕСПИРАТОРНО-СИНЦИТИАЛЬНЫМ ВИРУСОМ ЧЕЛОВЕКА И МЕТАПНЕВМОВИРУСОМ ЧЕЛОВЕКА | |
| Kailasa et al. | Electrospray ionization tandem mass spectrometry for rapid, sensitive and direct detection of melamine in dairy products | |
| JP2024515443A5 (enExample) | ||
| Rincón et al. | Evaluation of peripheral blood microsampling techniques in combination with liquid chromatography‐high resolution mass spectrometry for the determination of drug pharmacokinetics in clinical studies | |
| BR112022004390A2 (pt) | Métodos de lc-ms para isotipagem e quantificação de anticorpos | |
| Schreiber et al. | LC-MS/MS analysis of emerging food contaminants | |
| RU2015104248A (ru) | Способ идентификации органических соединений методом хроматр-масс-спектрометрии | |
| Qi-Sheng et al. | Analysis of ISG15-modified proteins from A549 cells in response to influenza virus infection by liquid chromatography-tandem mass spectrometry |